| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,357 | 6,012 | 12,913 | 11,942 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 10,357 | 6,012 | 12,913 | 11,942 | | | Operating Expenses | | Research Development | 7,259 | 6,757 | 7,334 | 8,157 | | Selling General and Administrative | 2,440 | 1,984 | 2,225 | 2,259 | | Non Recurring | 500 |
-
| (500) | 4,509 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 678 | (2,729) | 3,854 | (2,983) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 672 | 188 | 270 | 384 | | Earnings Before Interest And Taxes | 830 | (2,541) | 4,124 | (2,599) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 830 | (2,541) | 4,124 | (2,599) | | Income Tax Expense | (3) | (115) | 130 | (6) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 833 | (2,426) | 3,994 | (2,593) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 833 | (2,426) | 3,994 | (2,593) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $833 | ($2,426) | $3,994 | ($2,593) |
|
0.11% Nasdaq 
0.01%
Income Statement
